

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * actin-myosin filament sliding (GO:0033275) | 9.30308833 |
| 2 | * muscle filament sliding (GO:0030049) | 9.30308833 |
| 3 | sarcomere organization (GO:0045214) | 8.91303135 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.74056600 |
| 5 | * actin-mediated cell contraction (GO:0070252) | 7.69585236 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.63268113 |
| 7 | plasma membrane repair (GO:0001778) | 7.49794951 |
| 8 | cardiac myofibril assembly (GO:0055003) | 7.39297262 |
| 9 | myofibril assembly (GO:0030239) | 7.27676412 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.67708952 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.38022294 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.19525228 |
| 13 | skeletal muscle contraction (GO:0003009) | 6.07904026 |
| 14 | cardiac muscle contraction (GO:0060048) | 5.98522027 |
| 15 | actomyosin structure organization (GO:0031032) | 5.88292261 |
| 16 | striated muscle contraction (GO:0006941) | 5.84596558 |
| 17 | * actin filament-based movement (GO:0030048) | 5.81999557 |
| 18 | cardiac muscle cell development (GO:0055013) | 5.78559667 |
| 19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.70431836 |
| 20 | cardiac cell development (GO:0055006) | 5.43192236 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 5.17406555 |
| 22 | regulation of actin filament-based movement (GO:1903115) | 5.16800557 |
| 23 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.15089533 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.15088530 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 5.11407484 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.94367376 |
| 27 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.94139456 |
| 28 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.93208901 |
| 29 | carnitine shuttle (GO:0006853) | 4.82861820 |
| 30 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.80320876 |
| 31 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.77509033 |
| 32 | cardiac muscle hypertrophy (GO:0003300) | 4.70027678 |
| 33 | regulation of cell communication by electrical coupling (GO:0010649) | 4.68198669 |
| 34 | adult heart development (GO:0007512) | 4.63064667 |
| 35 | regulation of striated muscle contraction (GO:0006942) | 4.57460483 |
| 36 | muscle tissue morphogenesis (GO:0060415) | 4.56631214 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.53675821 |
| 38 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.51529304 |
| 39 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.49088325 |
| 40 | regulation of sarcomere organization (GO:0060297) | 4.46886479 |
| 41 | heart trabecula formation (GO:0060347) | 4.43766326 |
| 42 | * muscle contraction (GO:0006936) | 4.42602166 |
| 43 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.35540939 |
| 44 | skeletal muscle adaptation (GO:0043501) | 4.33186156 |
| 45 | myotube cell development (GO:0014904) | 4.27310082 |
| 46 | response to inactivity (GO:0014854) | 4.25545469 |
| 47 | creatine metabolic process (GO:0006600) | 4.22855721 |
| 48 | regulation of membrane repolarization (GO:0060306) | 4.13559254 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 4.12718024 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06335700 |
| 51 | * muscle system process (GO:0003012) | 4.06188277 |
| 52 | striated muscle cell development (GO:0055002) | 4.01807576 |
| 53 | heart process (GO:0003015) | 4.00187369 |
| 54 | heart contraction (GO:0060047) | 4.00187369 |
| 55 | muscle hypertrophy (GO:0014896) | 3.98396906 |
| 56 | skeletal muscle tissue development (GO:0007519) | 3.93664219 |
| 57 | regulation of myoblast differentiation (GO:0045661) | 3.85792705 |
| 58 | striated muscle adaptation (GO:0014888) | 3.83253550 |
| 59 | striated muscle atrophy (GO:0014891) | 3.81288727 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 3.77468632 |
| 61 | muscle fiber development (GO:0048747) | 3.76224625 |
| 62 | regulation of the force of heart contraction (GO:0002026) | 3.73681669 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 3.70373308 |
| 64 | regulation of coenzyme metabolic process (GO:0051196) | 3.70373308 |
| 65 | cell communication involved in cardiac conduction (GO:0086065) | 3.67503970 |
| 66 | muscle organ development (GO:0007517) | 3.61649284 |
| 67 | positive regulation of myotube differentiation (GO:0010831) | 3.58027077 |
| 68 | muscle structure development (GO:0061061) | 3.57826581 |
| 69 | carnitine transmembrane transport (GO:1902603) | 3.57010269 |
| 70 | negative regulation of potassium ion transport (GO:0043267) | 3.56801928 |
| 71 | regulation of ATPase activity (GO:0043462) | 3.55638923 |
| 72 | regulation of ATP catabolic process (GO:1903289) | 3.55638923 |
| 73 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.51529179 |
| 74 | muscle cell development (GO:0055001) | 3.48656067 |
| 75 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.46795355 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.44937523 |
| 77 | cellular response to epinephrine stimulus (GO:0071872) | 3.44013865 |
| 78 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.43082165 |
| 79 | skeletal muscle fiber development (GO:0048741) | 3.42666481 |
| 80 | regulation of cardioblast differentiation (GO:0051890) | 3.42278115 |
| 81 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.41565029 |
| 82 | muscle hypertrophy in response to stress (GO:0003299) | 3.41565029 |
| 83 | cardiac muscle adaptation (GO:0014887) | 3.41565029 |
| 84 | cardiac muscle cell action potential (GO:0086001) | 3.40440022 |
| 85 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.39297962 |
| 86 | negative regulation of heart growth (GO:0061117) | 3.39297962 |
| 87 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37666490 |
| 88 | response to epinephrine (GO:0071871) | 3.37582516 |
| 89 | regulation of muscle contraction (GO:0006937) | 3.36243580 |
| 90 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.35809200 |
| 91 | response to muscle activity (GO:0014850) | 3.35419831 |
| 92 | regulation of heart rate (GO:0002027) | 3.30334614 |
| 93 | positive regulation of cation channel activity (GO:2001259) | 3.29978424 |
| 94 | positive regulation of myoblast differentiation (GO:0045663) | 3.28027546 |
| 95 | muscle cell cellular homeostasis (GO:0046716) | 3.27728674 |
| 96 | regulation of cardiac muscle contraction (GO:0055117) | 3.25826252 |
| 97 | glycogen biosynthetic process (GO:0005978) | 3.25602003 |
| 98 | glucan biosynthetic process (GO:0009250) | 3.25602003 |
| 99 | detection of calcium ion (GO:0005513) | 3.25370257 |
| 100 | response to caffeine (GO:0031000) | 3.25030584 |
| 101 | carnitine transport (GO:0015879) | 3.23903756 |
| 102 | amino-acid betaine transport (GO:0015838) | 3.23903756 |
| 103 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.20664588 |
| 104 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.20664588 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19498165 |
| 106 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.18831450 |
| 107 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.18831450 |
| 108 | cell communication by electrical coupling (GO:0010644) | 3.18529294 |
| 109 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.18246620 |
| 110 | negative regulation of muscle hypertrophy (GO:0014741) | 3.18027801 |
| 111 | muscle adaptation (GO:0043500) | 3.18023374 |
| 112 | NADH metabolic process (GO:0006734) | 3.17987990 |
| 113 | muscle atrophy (GO:0014889) | 3.17535204 |
| 114 | muscle cell fate commitment (GO:0042693) | 3.17046491 |
| 115 | regulation of p38MAPK cascade (GO:1900744) | 3.16546296 |
| 116 | regulation of muscle system process (GO:0090257) | 3.14671292 |
| 117 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.13981055 |
| 118 | glycogen catabolic process (GO:0005980) | 3.09101901 |
| 119 | regulation of sequestering of triglyceride (GO:0010889) | 3.04630325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.51251733 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.77468214 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.58144960 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.48643315 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.48643315 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.30982188 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.23679765 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.86599189 |
| 9 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.82345286 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65079767 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.62137319 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40054616 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.35749136 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.33136409 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.27884076 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24955939 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21883629 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21277944 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20968112 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.08558721 |
| 21 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.93615378 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.85950433 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78673124 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78182313 |
| 25 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75355112 |
| 26 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.74151890 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69372313 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62290766 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61645913 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60553068 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60445159 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60175671 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53699161 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53125913 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.50935065 |
| 36 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49325429 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48183237 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45823269 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43067302 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39347687 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38031587 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37683858 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.37515965 |
| 44 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35592750 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35419847 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32637416 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32492813 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32192972 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31949200 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31531952 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28305832 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26802286 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26387790 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22990230 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21813831 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21693894 |
| 57 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21243888 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20976000 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20444847 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19605797 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16642515 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15773344 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14769219 |
| 64 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13888434 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12630572 |
| 66 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11281798 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.10610976 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.10610976 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10317859 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08541459 |
| 71 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07292789 |
| 72 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06994411 |
| 73 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06273127 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06243332 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05954890 |
| 76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03999547 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03843857 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02816541 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02264628 |
| 80 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01794048 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00514723 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00104827 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98274991 |
| 84 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98033579 |
| 85 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97577318 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96980762 |
| 87 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96760869 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96463207 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96431929 |
| 90 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95695582 |
| 91 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94794405 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94635599 |
| 93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93389643 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.93291664 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92870166 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91710582 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91329131 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91329131 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91137187 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90906867 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90735348 |
| 102 | P68_20966046_ChIP-Seq_HELA_Human | 0.90674246 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90316307 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90190125 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87578973 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87397011 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86591530 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85681109 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85676245 |
| 110 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85529755 |
| 111 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85261056 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85048424 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84966365 |
| 114 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84908615 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84569926 |
| 116 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83958055 |
| 117 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83625787 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83325872 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83220579 |
| 120 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82755815 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82609625 |
| 122 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81785899 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81636236 |
| 124 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81636236 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81635802 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81518815 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81382571 |
| 128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81282462 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80991419 |
| 130 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80370122 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79495069 |
| 132 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79006391 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78428969 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76638132 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76370275 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76045282 |
| 137 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.75980295 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74717073 |
| 139 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.73891829 |
| 140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.73039015 |
| 141 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72433319 |
| 142 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.72175772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 5.97526990 |
| 2 | MP0003646_muscle_fatigue | 5.25701241 |
| 3 | * MP0002837_dystrophic_cardiac_calcinosis | 5.01229253 |
| 4 | * MP0000749_muscle_degeneration | 4.63529567 |
| 5 | * MP0004084_abnormal_cardiac_muscle | 4.42331866 |
| 6 | * MP0004036_abnormal_muscle_relaxation | 3.97722389 |
| 7 | * MP0004215_abnormal_myocardial_fiber | 3.65529429 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.64531097 |
| 9 | MP0000750_abnormal_muscle_regeneration | 3.51114507 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.46595356 |
| 11 | * MP0005330_cardiomyopathy | 3.42478996 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.25147945 |
| 13 | MP0000747_muscle_weakness | 2.92288098 |
| 14 | * MP0005620_abnormal_muscle_contractility | 2.86415478 |
| 15 | * MP0002972_abnormal_cardiac_muscle | 2.69692278 |
| 16 | MP0005369_muscle_phenotype | 2.68415224 |
| 17 | * MP0000759_abnormal_skeletal_muscle | 2.65841994 |
| 18 | * MP0002269_muscular_atrophy | 2.63676568 |
| 19 | MP0004130_abnormal_muscle_cell | 2.49977674 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.43207061 |
| 21 | * MP0010630_abnormal_cardiac_muscle | 2.35944404 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.29973329 |
| 23 | MP0004484_altered_response_of | 2.21755539 |
| 24 | * MP0005385_cardiovascular_system_phenoty | 2.18625346 |
| 25 | * MP0001544_abnormal_cardiovascular_syste | 2.18625346 |
| 26 | MP0004233_abnormal_muscle_weight | 2.06020059 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.87179487 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.79021401 |
| 29 | MP0003828_pulmonary_edema | 1.77575705 |
| 30 | MP0000733_abnormal_muscle_development | 1.73894299 |
| 31 | * MP0006138_congestive_heart_failure | 1.70219175 |
| 32 | MP0004085_abnormal_heartbeat | 1.64134182 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.62562760 |
| 34 | MP0004510_myositis | 1.61318767 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.48233843 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.45972924 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.45204374 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.43853379 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.42941610 |
| 40 | MP0005275_abnormal_skin_tensile | 1.39022014 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.33397003 |
| 42 | MP0003279_aneurysm | 1.33188865 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 1.32788018 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.29849089 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.25672631 |
| 46 | MP0005670_abnormal_white_adipose | 1.15090256 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.14170928 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.11717725 |
| 49 | MP0000343_altered_response_to | 1.11201998 |
| 50 | MP0004270_analgesia | 1.09668550 |
| 51 | MP0001661_extended_life_span | 1.08607041 |
| 52 | * MP0000266_abnormal_heart_morphology | 1.05992518 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.05858536 |
| 54 | MP0005623_abnormal_meninges_morphology | 1.05268455 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.04713313 |
| 56 | MP0004272_abnormal_basement_membrane | 0.95200454 |
| 57 | MP0005165_increased_susceptibility_to | 0.91348577 |
| 58 | MP0002971_abnormal_brown_adipose | 0.87600965 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.79828510 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.79634200 |
| 61 | * MP0002128_abnormal_blood_circulation | 0.77216846 |
| 62 | MP0001958_emphysema | 0.75088687 |
| 63 | MP0000230_abnormal_systemic_arterial | 0.73499413 |
| 64 | MP0005503_abnormal_tendon_morphology | 0.72404035 |
| 65 | * MP0000767_abnormal_smooth_muscle | 0.67890174 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.65585391 |
| 67 | MP0009840_abnormal_foam_cell | 0.54182122 |
| 68 | MP0002925_abnormal_cardiovascular_devel | 0.52936894 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.51898025 |
| 70 | * MP0005266_abnormal_metabolism | 0.51428221 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 0.48028184 |
| 72 | MP0001299_abnormal_eye_distance/ | 0.48001209 |
| 73 | MP0006054_spinal_hemorrhage | 0.46539722 |
| 74 | MP0003045_fibrosis | 0.46234441 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.44695766 |
| 76 | * MP0001614_abnormal_blood_vessel | 0.44631329 |
| 77 | MP0003879_abnormal_hair_cell | 0.44420486 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.43168979 |
| 79 | MP0005451_abnormal_body_composition | 0.41829857 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.41366562 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.40897412 |
| 82 | MP0004147_increased_porphyrin_level | 0.39887607 |
| 83 | MP0001784_abnormal_fluid_regulation | 0.39538228 |
| 84 | MP0010030_abnormal_orbit_morphology | 0.38877903 |
| 85 | MP0000762_abnormal_tongue_morphology | 0.37309734 |
| 86 | MP0003948_abnormal_gas_homeostasis | 0.37025996 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.36702662 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.35859786 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.35856107 |
| 90 | MP0004043_abnormal_pH_regulation | 0.35717815 |
| 91 | MP0003091_abnormal_cell_migration | 0.34100909 |
| 92 | MP0003941_abnormal_skin_development | 0.32770322 |
| 93 | MP0003385_abnormal_body_wall | 0.32687684 |
| 94 | MP0008569_lethality_at_weaning | 0.32558301 |
| 95 | MP0005166_decreased_susceptibility_to | 0.32455722 |
| 96 | MP0005187_abnormal_penis_morphology | 0.31731554 |
| 97 | MP0000249_abnormal_blood_vessel | 0.30488090 |
| 98 | MP0002060_abnormal_skin_morphology | 0.29422809 |
| 99 | MP0005334_abnormal_fat_pad | 0.27101646 |
| 100 | MP0009250_abnormal_appendicular_skeleto | 0.26873862 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.26811203 |
| 102 | MP0002114_abnormal_axial_skeleton | 0.26615169 |
| 103 | MP0009115_abnormal_fat_cell | 0.26514850 |
| 104 | MP0000579_abnormal_nail_morphology | 0.25799543 |
| 105 | MP0001765_abnormal_ion_homeostasis | 0.25699575 |
| 106 | MP0002796_impaired_skin_barrier | 0.25382373 |
| 107 | MP0008004_abnormal_stomach_pH | 0.24605111 |
| 108 | MP0003984_embryonic_growth_retardation | 0.24548596 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.24258864 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.22776856 |
| 111 | * MP0005376_homeostasis/metabolism_phenot | 0.21516603 |
| 112 | MP0005535_abnormal_body_temperature | 0.20063686 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.19695908 |
| 114 | MP0001943_abnormal_respiration | 0.19467442 |
| 115 | MP0005452_abnormal_adipose_tissue | 0.18502715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.46902144 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.44495108 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.32541577 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.22693373 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 6.18959721 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.11112960 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.10312414 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.02573141 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 5.99028223 |
| 10 | Nemaline bodies (HP:0003798) | 5.59265278 |
| 11 | Ventricular tachycardia (HP:0004756) | 5.14918168 |
| 12 | * Abnormality of the calf musculature (HP:0001430) | 4.92339116 |
| 13 | Increased connective tissue (HP:0009025) | 4.76513941 |
| 14 | * Hyporeflexia of lower limbs (HP:0002600) | 4.75148873 |
| 15 | Difficulty running (HP:0009046) | 4.53453557 |
| 16 | Distal arthrogryposis (HP:0005684) | 4.51312500 |
| 17 | Subaortic stenosis (HP:0001682) | 4.50602080 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.50602080 |
| 19 | * EMG: myopathic abnormalities (HP:0003458) | 4.44667462 |
| 20 | Myoglobinuria (HP:0002913) | 4.44461364 |
| 21 | Atrial fibrillation (HP:0005110) | 4.20310161 |
| 22 | Round ear (HP:0100830) | 4.13454021 |
| 23 | * Lipoatrophy (HP:0100578) | 4.03009681 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 3.91765027 |
| 25 | Myopathic facies (HP:0002058) | 3.89042644 |
| 26 | Difficulty climbing stairs (HP:0003551) | 3.83583240 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.80088548 |
| 28 | Supraventricular tachycardia (HP:0004755) | 3.77426097 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.72880875 |
| 30 | Supraventricular arrhythmia (HP:0005115) | 3.72749595 |
| 31 | Myotonia (HP:0002486) | 3.65779408 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.57541689 |
| 33 | Ulnar deviation of the wrist (HP:0003049) | 3.56954160 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.48169414 |
| 35 | * Dilated cardiomyopathy (HP:0001644) | 3.37670452 |
| 36 | Bundle branch block (HP:0011710) | 3.31884560 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.28643352 |
| 38 | Syncope (HP:0001279) | 3.24209803 |
| 39 | * Right ventricular cardiomyopathy (HP:0011663) | 3.20885732 |
| 40 | Palpitations (HP:0001962) | 3.17933786 |
| 41 | Prolonged QT interval (HP:0001657) | 3.10929837 |
| 42 | Ventricular arrhythmia (HP:0004308) | 3.01780952 |
| 43 | * Neck muscle weakness (HP:0000467) | 2.94857691 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.94089127 |
| 45 | Gowers sign (HP:0003391) | 2.92097775 |
| 46 | Muscle stiffness (HP:0003552) | 2.91412495 |
| 47 | Calcaneovalgus deformity (HP:0001848) | 2.83042410 |
| 48 | Heart block (HP:0012722) | 2.81613004 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 2.76502085 |
| 50 | Atrioventricular block (HP:0001678) | 2.75564298 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.75199920 |
| 52 | Facial diplegia (HP:0001349) | 2.74959267 |
| 53 | Fatigable weakness (HP:0003473) | 2.72542010 |
| 54 | Abnormality of the neuromuscular junction (HP:0003398) | 2.72542010 |
| 55 | Areflexia of lower limbs (HP:0002522) | 2.65697046 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.65221325 |
| 57 | Deformed tarsal bones (HP:0008119) | 2.59884563 |
| 58 | Generalized muscle weakness (HP:0003324) | 2.59865447 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.54738019 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.54312537 |
| 61 | Frequent falls (HP:0002359) | 2.52489737 |
| 62 | Ventricular fibrillation (HP:0001663) | 2.52139202 |
| 63 | EMG: neuropathic changes (HP:0003445) | 2.51673191 |
| 64 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.49993176 |
| 65 | Spinal rigidity (HP:0003306) | 2.49321436 |
| 66 | Weak cry (HP:0001612) | 2.45183304 |
| 67 | Testicular atrophy (HP:0000029) | 2.40005382 |
| 68 | Rimmed vacuoles (HP:0003805) | 2.39064447 |
| 69 | Popliteal pterygium (HP:0009756) | 2.33439118 |
| 70 | Hip contracture (HP:0003273) | 2.27348754 |
| 71 | Muscular dystrophy (HP:0003560) | 2.22501783 |
| 72 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 2.17901564 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.17671043 |
| 74 | * Scapular winging (HP:0003691) | 2.16900535 |
| 75 | Muscle fiber atrophy (HP:0100295) | 2.12952722 |
| 76 | Abnormal EKG (HP:0003115) | 2.12934950 |
| 77 | Hypoplastic ischia (HP:0003175) | 2.12236762 |
| 78 | Broad metatarsal (HP:0001783) | 2.05610742 |
| 79 | Proximal amyotrophy (HP:0007126) | 2.03269425 |
| 80 | Abnormal finger flexion creases (HP:0006143) | 2.01708893 |
| 81 | Limb-girdle muscle weakness (HP:0003325) | 2.01467694 |
| 82 | * Foot dorsiflexor weakness (HP:0009027) | 1.99811627 |
| 83 | Left ventricular hypertrophy (HP:0001712) | 1.99200465 |
| 84 | Lower limb amyotrophy (HP:0007210) | 1.98892094 |
| 85 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.98049202 |
| 86 | Easy fatigability (HP:0003388) | 1.97919680 |
| 87 | Aplasia of the musculature (HP:0100854) | 1.95015469 |
| 88 | Slender build (HP:0001533) | 1.94603354 |
| 89 | * Palmoplantar keratoderma (HP:0000982) | 1.93415447 |
| 90 | Steppage gait (HP:0003376) | 1.92485812 |
| 91 | Hypoplastic heart (HP:0001961) | 1.92339756 |
| 92 | * Bulbar palsy (HP:0001283) | 1.85799160 |
| 93 | Abnormality of the ischium (HP:0003174) | 1.83896719 |
| 94 | Progressive muscle weakness (HP:0003323) | 1.83464823 |
| 95 | Conjunctival hamartoma (HP:0100780) | 1.79976710 |
| 96 | Aortic aneurysm (HP:0004942) | 1.78074769 |
| 97 | Abnormality of placental membranes (HP:0011409) | 1.77320109 |
| 98 | Amniotic constriction ring (HP:0009775) | 1.77320109 |
| 99 | Abnormality of the calcaneus (HP:0008364) | 1.76919247 |
| 100 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.74860730 |
| 101 | Type 2 muscle fiber atrophy (HP:0003554) | 1.71691324 |
| 102 | Nonprogressive disorder (HP:0003680) | 1.71046393 |
| 103 | * Limb-girdle muscle atrophy (HP:0003797) | 1.64051346 |
| 104 | Thin ribs (HP:0000883) | 1.62903097 |
| 105 | Ketoacidosis (HP:0001993) | 1.62632114 |
| 106 | Long clavicles (HP:0000890) | 1.60869839 |
| 107 | Generalized amyotrophy (HP:0003700) | 1.59681263 |
| 108 | Sudden cardiac death (HP:0001645) | 1.58353042 |
| 109 | Waddling gait (HP:0002515) | 1.58055017 |
| 110 | * Abnormality of the foot musculature (HP:0001436) | 1.57314251 |
| 111 | Limited hip movement (HP:0008800) | 1.57246422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.61313294 |
| 2 | OBSCN | 5.44404636 |
| 3 | PHKG2 | 3.91566396 |
| 4 | PHKG1 | 3.91566396 |
| 5 | MYLK | 3.58382195 |
| 6 | TRIB3 | 3.49761493 |
| 7 | DMPK | 3.11306024 |
| 8 | LMTK2 | 2.75109762 |
| 9 | PKN2 | 2.74780556 |
| 10 | MUSK | 2.72437393 |
| 11 | PDK4 | 2.61770923 |
| 12 | PDK3 | 2.61770923 |
| 13 | PIK3CG | 2.42138500 |
| 14 | PIK3CA | 2.12006177 |
| 15 | NEK1 | 1.87724663 |
| 16 | PDK2 | 1.84249465 |
| 17 | BCKDK | 1.81708169 |
| 18 | MAPKAPK3 | 1.52262529 |
| 19 | TIE1 | 1.52027749 |
| 20 | PINK1 | 1.49275792 |
| 21 | MAP2K3 | 1.46305436 |
| 22 | NME1 | 1.42729107 |
| 23 | ILK | 1.36632461 |
| 24 | MAP3K7 | 1.35177251 |
| 25 | STK24 | 1.29076453 |
| 26 | MAPK12 | 1.23793546 |
| 27 | RIPK1 | 1.21388283 |
| 28 | PDGFRA | 1.03433957 |
| 29 | PRKD1 | 1.00890522 |
| 30 | TRPM7 | 0.99347674 |
| 31 | PAK3 | 0.97069852 |
| 32 | EPHB1 | 0.96066650 |
| 33 | MAP3K3 | 0.93795925 |
| 34 | TGFBR2 | 0.92676974 |
| 35 | MARK1 | 0.88904607 |
| 36 | CAMK2D | 0.85095332 |
| 37 | ERN1 | 0.81308678 |
| 38 | CDC42BPA | 0.75958224 |
| 39 | CCNB1 | 0.75925036 |
| 40 | MARK3 | 0.75130675 |
| 41 | MAP3K5 | 0.72549621 |
| 42 | PRKAA1 | 0.72128963 |
| 43 | MAP3K6 | 0.70108181 |
| 44 | PTK6 | 0.70044742 |
| 45 | DAPK3 | 0.68830189 |
| 46 | EPHB2 | 0.68525861 |
| 47 | * ROCK1 | 0.68521228 |
| 48 | PRKAA2 | 0.68348586 |
| 49 | SIK1 | 0.65215422 |
| 50 | STK38L | 0.62091758 |
| 51 | MAPK4 | 0.60003710 |
| 52 | MAPK7 | 0.58276317 |
| 53 | AKT2 | 0.58205078 |
| 54 | LATS1 | 0.57500317 |
| 55 | MAP3K10 | 0.56348608 |
| 56 | GRK7 | 0.55581123 |
| 57 | ICK | 0.55447761 |
| 58 | ZAK | 0.55111774 |
| 59 | NEK9 | 0.54716874 |
| 60 | FLT3 | 0.54347866 |
| 61 | FER | 0.54278899 |
| 62 | EEF2K | 0.53599307 |
| 63 | KSR2 | 0.53113805 |
| 64 | MAP3K13 | 0.52934601 |
| 65 | LRRK2 | 0.52768795 |
| 66 | SGK3 | 0.51570297 |
| 67 | MOS | 0.51541799 |
| 68 | SGK2 | 0.50116683 |
| 69 | MAP3K1 | 0.49914471 |
| 70 | PTK2B | 0.49374543 |
| 71 | CAMK2G | 0.48939525 |
| 72 | FGFR4 | 0.47131362 |
| 73 | CAMK2B | 0.46002067 |
| 74 | PKN1 | 0.45184907 |
| 75 | MAP2K4 | 0.44234261 |
| 76 | PDPK1 | 0.43745549 |
| 77 | KDR | 0.42798867 |
| 78 | MAP2K1 | 0.42171625 |
| 79 | STK38 | 0.41763974 |
| 80 | PAK2 | 0.41450703 |
| 81 | RPS6KC1 | 0.40043020 |
| 82 | RPS6KL1 | 0.40043020 |
| 83 | MTOR | 0.38568843 |
| 84 | WNK4 | 0.38454637 |
| 85 | PAK4 | 0.38315513 |
| 86 | STK4 | 0.38001743 |
| 87 | ARAF | 0.37652819 |
| 88 | LIMK1 | 0.36821127 |
| 89 | MARK2 | 0.36065096 |
| 90 | LATS2 | 0.35220547 |
| 91 | SGK223 | 0.34916972 |
| 92 | SGK494 | 0.34916972 |
| 93 | INSRR | 0.34355536 |
| 94 | RPS6KA6 | 0.33418070 |
| 95 | CAMK2A | 0.31648665 |
| 96 | TAOK1 | 0.31575417 |
| 97 | * PRKACB | 0.30308264 |
| 98 | CAMK4 | 0.30106908 |
| 99 | EPHA3 | 0.28147808 |
| 100 | DYRK1B | 0.27263900 |
| 101 | NLK | 0.26543643 |
| 102 | RPS6KA3 | 0.26314576 |
| 103 | MAPK11 | 0.25840998 |
| 104 | PDK1 | 0.25480347 |
| 105 | WNK1 | 0.25418141 |
| 106 | DDR2 | 0.24516502 |
| 107 | MAP2K6 | 0.24128632 |
| 108 | PRKG2 | 0.23755790 |
| 109 | ERBB3 | 0.23000590 |
| 110 | RPS6KB1 | 0.22711481 |
| 111 | PRKCE | 0.22153702 |
| 112 | PRKG1 | 0.21816358 |
| 113 | * PRKACA | 0.21799317 |
| 114 | MAPK10 | 0.21359714 |
| 115 | BMX | 0.21144086 |
| 116 | PRKACG | 0.21083881 |
| 117 | MAP3K11 | 0.20775755 |
| 118 | RPS6KA1 | 0.20668274 |
| 119 | MAPKAPK2 | 0.20127998 |
| 120 | * ROCK2 | 0.20110195 |
| 121 | RET | 0.19570597 |
| 122 | CAMK1 | 0.19236346 |
| 123 | RPS6KA2 | 0.19114128 |
| 124 | FGFR1 | 0.18892303 |
| 125 | RAF1 | 0.16761806 |
| 126 | TBK1 | 0.14882854 |
| 127 | SGK1 | 0.12651929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.27194456 |
| 2 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.35102531 |
| 3 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.24212732 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.20664639 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.94498761 |
| 6 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.15679447 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78127706 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64620761 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41326728 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.36695192 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.24200016 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.21407019 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99886317 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85156265 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.84954394 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76300587 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73425229 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72010929 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47401423 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.43296858 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38917669 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36840905 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.32295656 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31392072 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22564848 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.22267779 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21283552 |
| 28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18415549 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.17548470 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.15717984 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10588480 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08258371 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06484372 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04304539 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00484700 |
| 36 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92736835 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90813379 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87241044 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83917630 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 0.83010299 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81815742 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81181451 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76860148 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 0.75635588 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74440544 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72808323 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72368439 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71579168 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67049044 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63967288 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63220226 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61235477 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58696007 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.58160300 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57924376 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.57201921 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56941033 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56511290 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56236346 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55265825 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51824725 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51316456 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.50400823 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49947048 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49304820 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46726077 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44316669 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44240343 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.43263698 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.42486277 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42000713 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41023489 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40823211 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.39512902 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39053330 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38267610 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37104980 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36395903 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35841889 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35507270 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33360620 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32849668 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32036891 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30959378 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30064313 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29888500 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29431918 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28250284 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27732581 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.27699421 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25810596 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25037134 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24024164 |
| 94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22512147 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22459172 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22258379 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21104849 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.20384624 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19252089 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18496248 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18045843 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17505668 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16816269 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16704395 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16698170 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.16371690 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.16312719 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15375975 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14652373 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14589074 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14574861 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.14521079 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.14379242 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14170479 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13795452 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.13264679 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.13198948 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11946328 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.10229933 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.08041927 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07747788 |

